Skip to main content
. 2022 Mar 22;12:832765. doi: 10.3389/fonc.2022.832765

Figure 8.

Figure 8

PD-1/CD28 CSR and IL-4/7 ICR. In T cells: (A) the PD-1/CD28 CSR converts inhibitory signals delivered by PD-1 into activation signals, whereas (B) the IL-4/7 ICR converts inhibitory signals delivered by IL-4 into activation signals. The IL-4/7ICR can improve the proliferation and persistence of CAR-T cells in an IL-4-rich tumor microenvironment. (C) The PD-1/CD28 CSR and the IL-4/7 ICR are both injected into CAR-T cells simultaneously.